Weigh Pros and Cons of Meds for Primary Prevention of Breast Cancer

You'll see renewed interest in meds to prevent breast cancer...due to updated U.S. Preventive Services Task Force recommendations.

Use shared decision-making to discuss prevention for women over 35 with other risks, such as atypical hyperplasia or a first-degree relative with breast cancer...or for BRCA mutation carriers who don't want surgery.

Tell women to expect hot flashes with any preventive option. And explain that they'll need to take these meds for 5 years.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote